[1] |
Hui DSC,Zumla A, Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infectious disease clinics of North America. 2019 Dec; [PubMed PMID: 31668196] |
[2] |
Azhar EI,Hui DSC,Memish ZA,Drosten C,Zumla A, The Middle East Respiratory Syndrome (MERS). Infectious disease clinics of North America. 2019 Dec; [PubMed PMID: 31668197] |
[3] |
Perlman S,Netland J, Coronaviruses post-SARS: update on replication and pathogenesis. Nature reviews. Microbiology. 2009 Jun [PubMed PMID: 19430490] |
[4] |
Flaxman S,Mishra S,Gandy A,Unwin HJT,Mellan TA,Coupland H,Whittaker C,Zhu H,Berah T,Eaton JW,Monod M,Ghani AC,Donnelly CA,Riley SM,Vollmer MAC,Ferguson NM,Okell LC,Bhatt S, Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 Jun 8 [PubMed PMID: 32512579] |
[5] |
Clark A,Jit M,Warren-Gash C,Guthrie B,Wang HHX,Mercer SW,Sanderson C,McKee M,Troeger C,Ong KL,Checchi F,Perel P,Joseph S,Gibbs HP,Banerjee A,Eggo RM, Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet. Global health. 2020 Jun 15 [PubMed PMID: 32553130] |
[6] |
Chan JF,To KK,Tse H,Jin DY,Yuen KY, Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends in microbiology. 2013 Oct; [PubMed PMID: 23770275] |
[7] |
Chen Y,Liu Q,Guo D, Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of medical virology. 2020 Apr [PubMed PMID: 31967327] |
[8] |
Chan JF,Kok KH,Zhu Z,Chu H,To KK,Yuan S,Yuen KY, Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes [PubMed PMID: 31987001] |
[9] |
Andersen KG,Rambaut A,Lipkin WI,Holmes EC,Garry RF, The proximal origin of SARS-CoV-2. Nature medicine. 2020 Apr [PubMed PMID: 32284615] |
[10] |
Guo ZD,Wang ZY,Zhang SF,Li X,Li L,Li C,Cui Y,Fu RB,Dong YZ,Chi XY,Zhang MY,Liu K,Cao C,Liu B,Zhang K,Gao YW,Lu B,Chen W, Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerging infectious diseases. 2020 Apr 10 [PubMed PMID: 32275497] |
[11] |
Lauer SA,Grantz KH,Bi Q,Jones FK,Zheng Q,Meredith HR,Azman AS,Reich NG,Lessler J, The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of internal medicine. 2020 May 5 [PubMed PMID: 32150748] |
[12] |
Li Q,Guan X,Wu P,Wang X,Zhou L,Tong Y,Ren R,Leung KSM,Lau EHY,Wong JY,Xing X,Xiang N,Wu Y,Li C,Chen Q,Li D,Liu T,Zhao J,Li M,Tu W,Chen C,Jin L,Yang R,Wang Q,Zhou S,Wang R,Liu H,Luo Y,Liu Y,Shao G,Li H,Tao Z,Yang Y,Deng Z,Liu B,Ma Z,Zhang Y,Shi G,Lam TTY,Wu JTK,Gao GF,Cowling BJ,Yang B,Leung GM,Feng Z, Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine. 2020 Jan 29; [PubMed PMID: 31995857] |
[13] |
Bauch CT,Lloyd-Smith JO,Coffee MP,Galvani AP, Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (Cambridge, Mass.). 2005 Nov; [PubMed PMID: 16222170] |
[14] |
Lei J,Kusov Y,Hilgenfeld R, Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral research. 2018 Jan [PubMed PMID: 29128390] |
[15] |
Song W,Gui M,Wang X,Xiang Y, Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS pathogens. 2018 Aug [PubMed PMID: 30102747] |
[16] |
de Abajo FJ,Rodríguez-Martín S,Lerma V,Mejía-Abril G,Aguilar M,García-Luque A,Laredo L,Laosa O,Centeno-Soto GA,Ángeles Gálvez M,Puerro M,González-Rojano E,Pedraza L,de Pablo I,Abad-Santos F,Rodríguez-Mañas L,Gil M,Tobías A,Rodríguez-Miguel A,Rodríguez-Puyol D, Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet (London, England). 2020 May 30 [PubMed PMID: 32416785] |
[17] |
Li MY,Li L,Zhang Y,Wang XS, Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious diseases of poverty. 2020 Apr 28 [PubMed PMID: 32345362] |
[18] |
Smith JC,Sausville EL,Girish V,Yuan ML,Vasudevan A,John KM,Sheltzer JM, Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract. Developmental cell. 2020 Jun 8 [PubMed PMID: 32425701] |
[19] |
Hoffmann M,Kleine-Weber H,Schroeder S,Krüger N,Herrler T,Erichsen S,Schiergens TS,Herrler G,Wu NH,Nitsche A,Müller MA,Drosten C,Pöhlmann S, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16 [PubMed PMID: 32142651] |
[20] |
Angeletti S,Benvenuto D,Bianchi M,Giovanetti M,Pascarella S,Ciccozzi M, COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. Journal of medical virology. 2020 Feb 21; [PubMed PMID: 32083328] |
[21] |
Ciceri F,Beretta L,Scandroglio AM,Colombo S,Landoni G,Ruggeri A,Peccatori J,D'Angelo A,De Cobelli F,Rovere-Querini P,Tresoldi M,Dagna L,Zangrillo A, Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 2020 Apr 15; [PubMed PMID: 32294809] |
[22] |
Conti P,Ronconi G,Caraffa A,Gallenga CE,Ross R,Frydas I,Kritas SK, Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. Journal of biological regulators and homeostatic agents. 2020 Mar 14 [PubMed PMID: 32171193] |
[23] |
Tian S,Hu W,Niu L,Liu H,Xu H,Xiao SY, Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020 Feb 27; [PubMed PMID: 32114094] |
[24] |
Zhang H,Zhou P,Wei Y,Yue H,Wang Y,Hu M,Zhang S,Cao T,Yang C,Li M,Guo G,Chen X,Chen Y,Lei M,Liu H,Zhao J,Peng P,Wang CY,Du R, Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19. Annals of internal medicine. 2020 May 5 [PubMed PMID: 32163542] |
[25] |
Menter T,Haslbauer JD,Nienhold R,Savic S,Hopfer H,Deigendesch N,Frank S,Turek D,Willi N,Pargger H,Bassetti S,Leuppi JD,Cathomas G,Tolnay M,Mertz KD,Tzankov A, Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology. 2020 May 4 [PubMed PMID: 32364264] |
[26] |
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y,Zhang L,Fan G,Xu J,Gu X,Cheng Z,Yu T,Xia J,Wei Y,Wu W,Xie X,Yin W,Li H,Liu M,Xiao Y,Gao H,Guo L,Xie J,Wang G,Jiang R,Gao Z,Jin Q,Wang J,Cao B, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020 Feb 15; [PubMed PMID: 31986264] |
[27] |
Wu Z,McGoogan JM, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24; [PubMed PMID: 32091533] |
[28] |
Kogan A,Segel MJ,Ram E,Raanani E,Peled-Potashnik Y,Levin S,Sternik L, Acute Respiratory Distress Syndrome following Cardiac Surgery: Comparison of the American-European Consensus Conference Definition versus the Berlin Definition. Respiration; international review of thoracic diseases. 2019; [PubMed PMID: 30650409] |
[29] |
Cheng Y,Luo R,Wang K,Zhang M,Wang Z,Dong L,Li J,Yao Y,Ge S,Xu G, Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international. 2020 May [PubMed PMID: 32247631] |
[30] |
Ronco C,Reis T,Husain-Syed F, Management of acute kidney injury in patients with COVID-19. The Lancet. Respiratory medicine. 2020 May 14 [PubMed PMID: 32416769] |
[31] |
Zhou F,Yu T,Du R,Fan G,Liu Y,Liu Z,Xiang J,Wang Y,Song B,Gu X,Guan L,Wei Y,Li H,Wu X,Xu J,Tu S,Zhang Y,Chen H,Cao B, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020 Mar 28 [PubMed PMID: 32171076] |
[32] |
Singer M,Deutschman CS,Seymour CW,Shankar-Hari M,Annane D,Bauer M,Bellomo R,Bernard GR,Chiche JD,Coopersmith CM,Hotchkiss RS,Levy MM,Marshall JC,Martin GS,Opal SM,Rubenfeld GD,van der Poll T,Vincent JL,Angus DC, The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23; [PubMed PMID: 26903338] |
[33] |
Seymour CW,Kennedy JN,Wang S,Chang CH,Elliott CF,Xu Z,Berry S,Clermont G,Cooper G,Gomez H,Huang DT,Kellum JA,Mi Q,Opal SM,Talisa V,van der Poll T,Visweswaran S,Vodovotz Y,Weiss JC,Yealy DM,Yende S,Angus DC, Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019 May 28; [PubMed PMID: 31104070] |
[34] |
Matics TJ,Sanchez-Pinto LN, Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA pediatrics. 2017 Oct 2; [PubMed PMID: 28783810] |
[35] |
Yang AP,Liu JP,Tao WQ,Li HM, The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology. 2020 Jul [PubMed PMID: 32304994] |
[36] |
Gattinoni L,Coppola S,Cressoni M,Busana M,Rossi S,Chiumello D, COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. American journal of respiratory and critical care medicine. 2020 May 15 [PubMed PMID: 32228035] |
[37] |
Hui DS,Chow BK,Lo T,Tsang OTY,Ko FW,Ng SS,Gin T,Chan MTV, Exhaled air dispersion during high-flow nasal cannula therapy {i}versus{/i} CPAP {i}via{/i} different masks. The European respiratory journal. 2019 Apr; [PubMed PMID: 30705129] |
[38] |
Wu CN,Xia LZ,Li KH,Ma WH,Yu DN,Qu B,Li BX,Cao Y, High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial. British journal of anaesthesia. 2020 Mar 19 [PubMed PMID: 32200994] |
[39] |
Ledford H, Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020 Jun 16 [PubMed PMID: 32546811] |
[40] |
Bimonte S,Crispo A,Amore A,Celentano E,Cuomo A,Cascella M, Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In vivo (Athens, Greece). 2020 Jun [PubMed PMID: 32503817] |
[41] |
Cao B,Wang Y,Wen D,Liu W,Wang J,Fan G,Ruan L,Song B,Cai Y,Wei M,Li X,Xia J,Chen N,Xiang J,Yu T,Bai T,Xie X,Zhang L,Li C,Yuan Y,Chen H,Li H,Huang H,Tu S,Gong F,Liu Y,Wei Y,Dong C,Zhou F,Gu X,Xu J,Liu Z,Zhang Y,Li H,Shang L,Wang K,Li K,Zhou X,Dong X,Qu Z,Lu S,Hu X,Ruan S,Luo S,Wu J,Peng L,Cheng F,Pan L,Zou J,Jia C,Wang J,Liu X,Wang S,Wu X,Ge Q,He J,Zhan H,Qiu F,Guo L,Huang C,Jaki T,Hayden FG,Horby PW,Zhang D,Wang C, A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. The New England journal of medicine. 2020 May 7 [PubMed PMID: 32187464] |
[42] |
Gordon CJ,Tchesnokov EP,Feng JY,Porter DP,Gotte M, The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. The Journal of biological chemistry. 2020 Feb 24; [PubMed PMID: 32094225] |
[43] |
de Wit E,Feldmann F,Cronin J,Jordan R,Okumura A,Thomas T,Scott D,Cihlar T,Feldmann H, Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proceedings of the National Academy of Sciences of the United States of America. 2020 Feb 13; [PubMed PMID: 32054787] |
[44] |
Williamson BN,Feldmann F,Schwarz B,Meade-White K,Porter DP,Schulz J,van Doremalen N,Leighton I,Yinda CK,Pérez-Pérez L,Okumura A,Lovaglio J,Hanley PW,Saturday G,Bosio CM,Anzick S,Barbian K,Cihlar T,Martens C,Scott DP,Munster VJ,de Wit E, Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020 Jun 9 [PubMed PMID: 32516797] |
[45] |
Chen N,Zhou M,Dong X,Qu J,Gong F,Han Y,Qiu Y,Wang J,Liu Y,Wei Y,Xia J,Yu T,Zhang X,Zhang L, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020 Feb 15 [PubMed PMID: 32007143] |
[46] |
Wang Z,Yang B,Li Q,Wen L,Zhang R, Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Mar 16 [PubMed PMID: 32176772] |
[47] |
Gautret P,Lagier JC,Parola P,Hoang VT,Meddeb L,Mailhe M,Doudier B,Courjon J,Giordanengo V,Vieira VE,Dupont HT,Honoré S,Colson P,Chabrière E,La Scola B,Rolain JM,Brouqui P,Raoult D, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International journal of antimicrobial agents. 2020 Mar 20 [PubMed PMID: 32205204] |
[48] |
Zarogoulidis P,Papanas N,Kioumis I,Chatzaki E,Maltezos E,Zarogoulidis K, Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. European journal of clinical pharmacology. 2012 May [PubMed PMID: 22105373] |
[49] |
Mercuro NJ,Yen CF,Shim DJ,Maher TR,McCoy CM,Zimetbaum PJ,Gold HS, Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA cardiology. 2020 May 1 [PubMed PMID: 32356863] |
[50] |
Kollias A,Kyriakoulis KG,Dimakakos E,Poulakou G,Stergiou GS,Syrigos K, Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. British journal of haematology. 2020 Jun [PubMed PMID: 32304577] |
[51] |
Buonaguro FM,Puzanov I,Ascierto PA, Anti-IL6R role in treatment of COVID-19-related ARDS. Journal of translational medicine. 2020 Apr 14 [PubMed PMID: 32290847] |
[52] |
Cavalli G,De Luca G,Campochiaro C,Della-Torre E,Ripa M,Canetti D,Oltolini C,Castiglioni B,Tassan Din C,Boffini N,Tomelleri A,Farina N,Ruggeri A,Rovere-Querini P,Di Lucca G,Martinenghi S,Scotti R,Tresoldi M,Ciceri F,Landoni G,Zangrillo A,Scarpellini P,Dagna L, Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. The Lancet Rheumatology. 2020 Jun [PubMed PMID: 32501454] |
[53] |
Roschewski M,Lionakis MS,Sharman JP,Roswarski J,Goy A,Monticelli MA,Roshon M,Wrzesinski SH,Desai JV,Zarakas MA,Collen J,Rose K,Hamdy A,Izumi R,Wright GW,Chung KK,Baselga J,Staudt LM,Wilson WH, Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Science immunology. 2020 Jun 5 [PubMed PMID: 32503877] |
[54] |
Kucharski AJ,Klepac P,Conlan AJK,Kissler SM,Tang ML,Fry H,Gog JR,Edmunds WJ, Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. The Lancet. Infectious diseases. 2020 Jun 15 [PubMed PMID: 32559451] |
[55] |
Zhu FC,Li YH,Guan XH,Hou LH,Wang WJ,Li JX,Wu SP,Wang BS,Wang Z,Wang L,Jia SY,Jiang HD,Wang L,Jiang T,Hu Y,Gou JB,Xu SB,Xu JJ,Wang XW,Wang W,Chen W, Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet (London, England). 2020 Jun 13 [PubMed PMID: 32450106] |
[56] |
Vittori A,Lerman J,Cascella M,Gomez-Morad AD,Marchetti G,Marinangeli F,Picardo SG, COVID-19 Pandemic ARDS Survivors: Pain after the Storm? Anesthesia and analgesia. 2020 Apr 27 [PubMed PMID: 32345855] |